Remetinostat (Standard)

Overview

Remetinostat (Standard) is the analytical standard of Remetinostat ( HY-100365 ). This product is intended for research and analytical applications. Remetinostat (SHP-141) is a hydroxamic acid-based histone deacetylase ( HDAC ) inhibitor. Remetinostat alleviates Imiquimod ( HY-B0180 )-induced psoriatic dermatitis. Remetinostat can be used for study of cutaneous T-cell lymphoma.

Application

Products | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Others | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > HDAC | Products > Signaling Pathways > Reference Standards

Product Information

• Catalog No.: HY-100365R
• CAS No.: 946150-57-8
• Molecular Formula: C16H21NO6
• Molecular Weight: 323.34
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source